$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Application of a Non-Linear multi-model Ayurveda Intervention in elderly COVID-19 patients- a retrospective case series 원문보기

Journal of Ayurveda and integrative medicine, v.13 no.1, 2022년, pp.100476 -   

Dinesh, K.S. (Department of Kaumarabhritya, Vaidyaratnam P S Varier Ayurveda College, Kottakkal. Edarikode (P.O), 676501, Malappuram District, Kerala, India) ,  Nazeema, P.K. (Department of Kaumarabhritya, Vaidyaratnam P S Varier Ayurveda College, Kottakkal. Edarikode (P.O), 676501, Malappuram District, Kerala, India) ,  Archana, Madhavi (AYUSH Public Health Initiative, Department of Kaumarabhritya, Vaidyaratnam P S Varier Ayurveda College, Kottakkal Edarikode (P.O), 676501, Malappuram District, Kerala, India) ,  Jayakrishnan, K. (Department of Swasthavritha, All India Institute of Ayurveda, Mathura Rd, Gautampuri Awas, Sarita Vihar, New Delhi, 110076, India) ,  Santhi Krishna, A.S. (Surya, Katampazhipuram, Palakkad, 678633, Kerala, India) ,  Swapna Chitra, S. (Department of Kaumarabhritya, Santhigiri Ayurveda Medical College, Olassery, Kodumba, Palakkad, 678551, Kerala, India) ,  Sujitha, V.K. (Department of Kaumarabhritya, Vaidyaratnam P S Varier Ayurveda College, Kottakkal. Edarikode (P.O), 676501, Malappuram District, Kerala, India) ,  Sathian, Anju (AYUSH Public Health Initiative, Department of Kaumarabhritya, Vaidyaratnam P S) ,  Girish Babu, M. ,  Balakrishnan, Geethu ,  Krishnendhu, C.

Abstract AI-Helper 아이콘AI-Helper

The COVID-19 pandemic is ravaging the world, leaving the mainstream medical system handicapped with no proven treatment at one end and the ambiguities regarding the efficacies of vaccines at the other. The elderly population is at greater risk in terms of complications and death. The use of compleme...

주제어

참고문헌 (24)

  1. 1 World Health Organization WHO coronavirus disease (COVID-19) dashboard https://covid19.who.int/?gclid=CjwKCAjwx9_4BRAHEiwApAt0zjQSOc06_i6ZgVeudtJmhr0RXXU4n44hGkJRIb8HelDQkHkYLSlNRxoCsKgQAvD_BwE 

  2. 2 World Health Organization Health workforce requirements for universal health coverage and the sustainable development goals 2016 WHO Geneva https://apps.who.int/iris/bitstream/handle/10665/250330/9789241511407-eng.pdf?sequence=1 

  3. 3 World Health Organization The health workforce in India 2016 WHO Geneva https://www.who.int/hrh/resources/16058health_workforce_India.pdf 

  4. 4 World Health Organization Responding to COVID-19 - learnings from Kerala 2016 WHO https://www.who.int/india/news/feature-stories/detail/responding-to-covid-19---learnings-from-kerala 

  5. 5 Chatterjee B. Pancholi J. Prakriti-based medicine: a step towards personalized medicine Ayu 32 2 2011 141 146 22408293 

  6. 6 Pal M. The tridosha theory Ancient Sci Life 10 3 1991 144 155 

  7. 7 Rioux J. A complex, nonlinear dynamic systems perspective on Ayurveda and Ayurvedic research [published correction appears in J Altern Complement Med. 2012 Oct;18(10):988] J Alternative Compl Med 18 7 2012 709 718 

  8. 8 Ministry of Ayush Covid - 19 related information 2020 https://www.ayush.gov.in/ 

  9. 9 Zhao Z. Li Y. Zhou L. Zhou X. Xie B. Zhang W. Prevention and treatment of COVID-19 using Traditional Chinese Medicine: a review Phytomedicine 85 2021 153308 10.1016/j.phymed.2020.153308 32843234 

  10. 10 Ren J.L. Zhang A.H. Wang X.J. Traditional Chinese medicine for COVID-19 treatment [published correction appears in Pharmacol Res. 2020 Mar 25;:104768] Pharmacol Res 155 2020 104743 32145402 

  11. 11 Tillu G. Salvi S. Patwardhan B. AYUSH for COVID-19 management J Ayurveda Integr Med 11 2 2020 95 96 32600556 

  12. 12 Rastogi S. Pandey D.N. Singh R.H. COVID-19 pandemic: a pragmatic plan for Ayurveda intervention J Ayurveda Integr Med 20 1016 2020 

  13. 13 Sadanandan R. Kerala's response to COVID-19 Indian J Publ Health 64 Supplement 2020 Jun S99 S101 10.4103/ijph.IJPH_459_20 PMID: 32496235 

  14. 14 Menon I. Spudich A. The Ashtavaidya physicians of Kerala: a tradition in transition J Ayurveda Integr Med 1 4 2010 245 250 21731370 

  15. 15 Mishra S.R. Ghimire S. Joshi C. Gyawali B. Shrestha A. Neupane D. Cardio-metabolic disease risk factors among South Asian labour migrants to the Middle East: a scoping review and policy analysis Glob Health 15 1 2019 33 

  16. 16 Lu H. Nie P. Qian L. Do quarantine experiences and attitudes towards COVID-19 affect the distribution of mental health in China? A quantile regression analysis Applied Research Quality Life 2020 1 18 10.1007/s11482-020-09851-0 

  17. 17 Chang D. Mo G. Yuan X. Tao Y. Peng X. Wang F.S. Time kinetics of viral clearance and resolution of symptoms in novel coronavirus infection Am J Respir Crit Care Med 201 9 2020 1150 1152 32200654 

  18. 18 Chen J. Qi T. Liu L. Ling Y. Qian Z. Li T. Clinical progression of patients with COVID-19 in Shanghai, China J Infect 80 5 2020 e1 e6 

  19. 19 Murphy T.E. McAvay G.J. Allore H.G. Stamm J.A. Simonelli P.F. Contributions of COPD, asthma, and ten comorbid conditions to health care utilization and patient-centered outcomes among US adults with obstructive airway disease Int J Chronic Obstr Pulm Dis 12 2017 Aug 23 2515 2522 10.2147/COPD.S139948 PMID: 28883718; PMCID: PMC5574692 

  20. 20 Wang X. Fang X. Cai Z. Wu X. Gao X. Min J. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among Covid-19 patients: a systemic review and meta-analysis Research 2020 2020 2402961 10.34133/2020/2402961 32377638 

  21. 21 Yang R. Gui X. Zhang Y. Xiong Y. The role of essential organ-based comorbidities in the prognosis of COVID-19 infection patients Expet Rev Respir Med 2020 1 4 10.1080/17476348.2020.1761791 

  22. 22 Singh A.K. Misra A. Impact of COVID-19 and comorbidities on health and economics: focus on developing countries and India Diabetes Metab Syndr 14 6 2020 1625 1630 10.1016/j.dsx.2020.08.032 32891011 

  23. 23 Guan W-jie Liang W-hua Zhao Y. Liang H. Chen Z. Li Y. Comorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis Eur Respir J 2020 10.1183/13993003.00547-2020 in press 

  24. 24 Ioannidis J.P.A. Axfors C. Contopoulos-Ioannidis D.G. Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters Environ Res 188 2020 109890 32846654 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로